Objectives-To analyse the explicit or implicit claims embodied in the proprietary names of pharmaceutical products.
Design-Linguistic and ethical analysis of proprietary names of pharmaceutical products marketed in the UK and in Denmark.
Results and conclusions-A number of drugs have names that allude to their indication or actions.
Such names may be problematic, however, because they often promise more than the drug can deliver.
Taking into account, firstly, the type of allusion and its degree of sophistication, and, secondly, the seriousness of the indication may help in identifying the most problematic drug names.
Mots-clés Pascal : Commercialisation, Médicament, Facteur diffusion, Efficacité traitement, Interaction médicamenteuse, Enquête utilité publique, Prévention, Homme, Indication, Organisation santé
Mots-clés Pascal anglais : Marketing, Drug, Scattering factor, Treatment efficiency, Drug interaction, Inquiry for public prosals, Prevention, Human, Indication, Public health organization
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 97-0075918
Code Inist : 002B30A08. Création : 21/05/1997.